Sg Americas Securities, LLC Ligand Pharmaceuticals Inc Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$68.53 - $87.91 $304,067 - $390,056	-4,437 Reduced 40.11%	6,624 $558,000
Q1 2024 May 06, 2024	BUY	$68.64 - $89.2 $759,227 - $986,641	11,061 New	11,061 $809,000
Q3 2023 Oct 13, 2023	BUY	$58.86 - $72.67 $365,814 - $451,644	6,215 Added 73.33%	14,690 $880,000
Q2 2023 Jul 10, 2023	SELL	$69.53 - $79.33 $1.06 Million - $1.21 Million	-15,308 Reduced 64.37%	8,475 $611,000
Q1 2023 Apr 28, 2023	SELL	$65.67 - $77.08 $922,991 - $1.08 Million	-14,055 Reduced 37.15%	23,783 $1.75 Million
Q4 2022 Feb 02, 2023	BUY	$61.72 - $96.74 $2.34 Million - $3.66 Million	37,838 New	37,838 $2.53 Million
Q2 2022 Jul 29, 2022	BUY	$74.52 - $117.06 $173,259 - $272,164	2,325 Added 40.8%	8,024 $716,000
Q1 2022 Apr 29, 2022	SELL	$94.99 - $151.56 $266,636 - $425,428	-2,807 Reduced 33.0%	5,699 $641,000
Q4 2021 Feb 07, 2022	BUY	$127.69 - $165.85 $766,395 - $995,431	6,002 Added 239.7%	8,506 $1.31 Million
Q3 2021 Nov 01, 2021	SELL	$102.33 - $144.73 $431,218 - $609,892	-4,214 Reduced 62.73%	2,504 $349,000
Q2 2021 Aug 12, 2021	BUY	$113.03 - $155.64 $211,931 - $291,825	1,875 Added 38.72%	6,718 $881,000
Q1 2021 May 13, 2021	SELL	$99.52 - $215.83 $797,752 - $1.73 Million	-8,016 Reduced 62.34%	4,843 $738,000
Q4 2020 Feb 04, 2021	BUY	$80.55 - $106.05 $376,490 - $495,677	4,674 Added 57.1%	12,859 $1.28 Million
Q3 2020 Nov 09, 2020	SELL	$89.56 - $126.72 $269,396 - $381,173	-3,008 Reduced 26.87%	8,185 $780,000
Q2 2020 Jul 20, 2020	BUY	$68.28 - $123.65 $311,083 - $563,349	4,556 Added 68.65%	11,193 $1.25 Million
Q1 2020 Apr 30, 2020	SELL	$63.37 - $107.88 $268,688 - $457,411	-4,240 Reduced 38.98%	6,637 $483,000
Q4 2019 Jan 28, 2020	BUY	$96.94 - $113.59 $914,241 - $1.07 Million	9,431 Added 652.21%	10,877 $1.13 Million
Q3 2019 Nov 04, 2019	SELL	$86.25 - $120.16 $134,808 - $187,810	-1,563 Reduced 51.94%	1,446 $144,000
Q2 2019 Jul 29, 2019	SELL	$107.38 - $129.34 $351,669 - $423,588	-3,275 Reduced 52.12%	3,009 $343,000
Q1 2019 Apr 29, 2019	SELL	$105.93 - $142.47 $885,574 - $1.19 Million	-8,360 Reduced 57.09%	6,284 $790,000
Q4 2018 Feb 01, 2019	BUY	$128.36 - $272.13 $1.27 Million - $2.7 Million	9,910 Added 209.34%	14,644 $1.99 Million
Q3 2018 Nov 06, 2018	SELL	$211.18 - $274.49 $1.18 Million - $1.53 Million	-5,582 Reduced 54.11%	4,734 $1.3 Million
Q2 2018 Aug 07, 2018	BUY	$150.77 - $207.98 $1.36 Million - $1.87 Million	8,994 Added 680.33%	10,316 $2.14 Million
Q1 2018 May 03, 2018	BUY	$138.63 - $182.62 $36,598 - $48,211	264 Added 24.95%	1,322 $218,000
Q4 2017 Jan 24, 2018	SELL	$128.36 - $147.04 $429,492 - $491,995	-3,346 Reduced 75.98%	1,058 $145,000
Q3 2017 Nov 07, 2017	BUY	$120.91 - $137.94 $532,487 - $607,487	4,404	4,404 $600,000

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account